Compare $ACUT vs $BIXT | Chartloom

Compare

$ACUT vs $BIXT

Accustem Sciences Inc · Bioxytran Inc

ACUT

Accustem Sciences Inc

BIXT

Bioxytran Inc

Compare $ACUT vs $BIXT

Comparing Accustem Sciences Inc and Bioxytran Inc

ACUTAccustem Sciences Inc

BIXTBioxytran Inc

ACUTAccustem Sciences Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-75.6%

52W performance

-67.3%

FCF yield

-50.9%

BIXTBioxytran Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-68.2%

52W performance

-67.7%

FCF yield

-34.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACUT

BIXT

Detailed metrics comparison

ACUT

Accustem Sciences Inc

BIXT

Bioxytran Inc

Market Cap

ACUT$2M

BIXT$3M

Enterprise Value

ACUT$2M

BIXT$4M

Price

ACUT$0.15

BIXT$0.02

P/E Ratio

ACUTN/A

BIXTN/A

P/S Ratio

ACUT0.00x

BIXT18.76x

EV/Sales

ACUT0.00x

BIXT19.26x

EV/EBITDA

ACUT0.00x

BIXT121.99x

P/B Ratio

ACUT2.97x

BIXT4.86x

P/FCF Ratio

ACUTN/A

BIXTN/A

EV/FCF

ACUT-2.01x

BIXT-4.08x

PEG Ratio

ACUTN/A

BIXTN/A

Forward P/E (NTM)

ACUTN/A

BIXTN/A

Forward P/S (NTM)

ACUTN/A

BIXTN/A

Revenue (TTM)

ACUT$0

BIXT$0

Revenue Growth (YoY)

ACUTN/A

BIXTN/A

Forward Rev Growth

ACUT0.0%

BIXT0.0%

Gross Margin (TTM)

ACUT0.0%

BIXT47.4%

Operating Margin (TTM)

ACUT0.0%

BIXT0.0%

EBITDA Margin (TTM)

ACUT0.0%

BIXT0.0%

Net Margin (TTM)

ACUT0.0%

BIXT0.0%

FCF Margin (TTM)

ACUTN/A

BIXTN/A

Net Income (TTM)

ACUT$-2M

BIXT$-3M

FCF (TTM)

ACUT$-1M

BIXT$-893K

EPS (TTM)

ACUT-$0.10

BIXT-$0.03

ROE (TTM)

ACUT-21712.9%

BIXT-755.0%

ROA (TTM)

ACUT-10530.0%

BIXT-79248.0%

ROIC (TTM)

ACUT-179413.5%

BIXT-612.0%

Cash

ACUT$13K

BIXT$177K

Debt

ACUT$63K

BIXT$1M

Net Cash/Debt

ACUT$-50K

BIXT$-1M

Current Ratio (TTM)

ACUT0.02x

BIXT0.03x

Quick Ratio (TTM)

ACUT0.00x

BIXT0.03x

Debt/Equity (TTM)

ACUT0.27x

BIXT0.20x

Debt/Assets (TTM)

ACUT0.0%

BIXT0.0%

Interest Coverage (TTM)

ACUTN/A

BIXTN/A

Net Debt/EBITDA (TTM)

ACUT0.00x

BIXT0.00x

Beta

ACUT1.88

BIXT2.80

52W Performance

ACUT-67.3%

BIXT-67.7%

YTD Performance

ACUT-75.6%

BIXT-68.2%

% from 52W High

ACUT-93.7%

BIXT-75.9%

% from 52W Low

ACUT26.0%

BIXT14.5%

Asset Turnover (TTM)

ACUT0.00x

BIXT0.50x

FCF Yield (TTM)

ACUT-50.9%

BIXT-34.2%

Earnings Yield (TTM)

ACUT-69.8%

BIXT-133.6%

Dividend Yield (TTM)

ACUTN/A

BIXTN/A

Rule of 40

ACUT0.0

BIXT0.0

EV/GP/RG

ACUTN/A

BIXTN/A

Ticker research

View ACUT research View BIXT research

Metric	ACUT Accustem Sciences Inc	BIXT Bioxytran Inc
Market & Valuation
Market Cap	$2M	$3M
Enterprise Value	$2M	$4M
Price	$0.15	$0.02
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	18.76x
EV/Sales	0.00x	19.26x
EV/EBITDA	0.00x	121.99x
P/B Ratio	2.97x	4.86x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.01x	-4.08x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	47.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-2M	$-3M
FCF (TTM)	$-1M	$-893K
EPS (TTM)	-$0.10	-$0.03
ROE (TTM)	-21712.9%	-755.0%
ROA (TTM)	-10530.0%	-79248.0%
ROIC (TTM)	-179413.5%	-612.0%
Financial Health
Cash	$13K	$177K
Debt	$63K	$1M
Net Cash/Debt	$-50K	$-1M
Current Ratio (TTM)	0.02x	0.03x
Quick Ratio (TTM)	0.00x	0.03x
Debt/Equity (TTM)	0.27x	0.20x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.88	2.80
52W Performance	-67.3%	-67.7%
YTD Performance	-75.6%	-68.2%
% from 52W High	-93.7%	-75.9%
% from 52W Low	26.0%	14.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.50x
FCF Yield (TTM)	-50.9%	-34.2%
Earnings Yield (TTM)	-69.8%	-133.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACUT research	View BIXT research

Valuation

P/S Ratio

ACUT

0.00x

BIXT

18.76x

EV/FCF

BIXT

-4.08x

ACUT

-2.01x

Growth & revenue

Forward Revenue Growth

ACUT

0.0%

BIXT

0.0%

Profitability & performance

Gross Margin

BIXT

47.4%

ACUT

0.0%

ROE

BIXT

-755.0%

ACUT

-21712.9%

FCF Yield %

BIXT

-34.2%

ACUT

-50.9%

52-Week Performance

ACUT

-67.3%

BIXT

-67.7%

Detailed metrics comparison

ACUT

Accustem Sciences Inc

BIXT

Bioxytran Inc

Market Cap

ACUT$2M

BIXT$3M

Enterprise Value

ACUT$2M

BIXT$4M

Price

ACUT$0.15

BIXT$0.02

P/E Ratio

ACUTN/A

BIXTN/A

P/S Ratio

ACUT0.00x

BIXT18.76x

EV/Sales

ACUT0.00x

BIXT19.26x

EV/EBITDA

ACUT0.00x

BIXT121.99x

P/B Ratio

ACUT2.97x

BIXT4.86x

P/FCF Ratio

ACUTN/A

BIXTN/A

EV/FCF

ACUT-2.01x

BIXT-4.08x

PEG Ratio

ACUTN/A

BIXTN/A

Forward P/E (NTM)

ACUTN/A

BIXTN/A

Forward P/S (NTM)

ACUTN/A

BIXTN/A

Revenue (TTM)

ACUT$0

BIXT$0

Revenue Growth (YoY)

ACUTN/A

BIXTN/A

Forward Rev Growth

ACUT0.0%

BIXT0.0%

Gross Margin (TTM)

ACUT0.0%

BIXT47.4%

Operating Margin (TTM)

ACUT0.0%

BIXT0.0%

EBITDA Margin (TTM)

ACUT0.0%

BIXT0.0%

Net Margin (TTM)

ACUT0.0%

BIXT0.0%

FCF Margin (TTM)

ACUTN/A

BIXTN/A

Net Income (TTM)

ACUT$-2M

BIXT$-3M

FCF (TTM)

ACUT$-1M

BIXT$-893K

EPS (TTM)

ACUT-$0.10

BIXT-$0.03

ROE (TTM)

ACUT-21712.9%

BIXT-755.0%

ROA (TTM)

ACUT-10530.0%

BIXT-79248.0%

ROIC (TTM)

ACUT-179413.5%

BIXT-612.0%

Cash

ACUT$13K

BIXT$177K

Debt

ACUT$63K

BIXT$1M

Net Cash/Debt

ACUT$-50K

BIXT$-1M

Current Ratio (TTM)

ACUT0.02x

BIXT0.03x

Quick Ratio (TTM)

ACUT0.00x

BIXT0.03x

Debt/Equity (TTM)

ACUT0.27x

BIXT0.20x

Debt/Assets (TTM)

ACUT0.0%

BIXT0.0%

Interest Coverage (TTM)

ACUTN/A

BIXTN/A

Net Debt/EBITDA (TTM)

ACUT0.00x

BIXT0.00x

Beta

ACUT1.88

BIXT2.80

52W Performance

ACUT-67.3%

BIXT-67.7%

YTD Performance

ACUT-75.6%

BIXT-68.2%

% from 52W High

ACUT-93.7%

BIXT-75.9%

% from 52W Low

ACUT26.0%

BIXT14.5%

Asset Turnover (TTM)

ACUT0.00x

BIXT0.50x

FCF Yield (TTM)

ACUT-50.9%

BIXT-34.2%

Earnings Yield (TTM)

ACUT-69.8%

BIXT-133.6%

Dividend Yield (TTM)

ACUTN/A

BIXTN/A

Rule of 40

ACUT0.0

BIXT0.0

EV/GP/RG

ACUTN/A

BIXTN/A

Ticker research

View ACUT research View BIXT research

Metric	ACUT Accustem Sciences Inc	BIXT Bioxytran Inc
Market & Valuation
Market Cap	$2M	$3M
Enterprise Value	$2M	$4M
Price	$0.15	$0.02
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	18.76x
EV/Sales	0.00x	19.26x
EV/EBITDA	0.00x	121.99x
P/B Ratio	2.97x	4.86x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.01x	-4.08x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	47.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-2M	$-3M
FCF (TTM)	$-1M	$-893K
EPS (TTM)	-$0.10	-$0.03
ROE (TTM)	-21712.9%	-755.0%
ROA (TTM)	-10530.0%	-79248.0%
ROIC (TTM)	-179413.5%	-612.0%
Financial Health
Cash	$13K	$177K
Debt	$63K	$1M
Net Cash/Debt	$-50K	$-1M
Current Ratio (TTM)	0.02x	0.03x
Quick Ratio (TTM)	0.00x	0.03x
Debt/Equity (TTM)	0.27x	0.20x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.88	2.80
52W Performance	-67.3%	-67.7%
YTD Performance	-75.6%	-68.2%
% from 52W High	-93.7%	-75.9%
% from 52W Low	26.0%	14.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.50x
FCF Yield (TTM)	-50.9%	-34.2%
Earnings Yield (TTM)	-69.8%	-133.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACUT research	View BIXT research